A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/48 (2006.01)
Patent
CA 2608376
The invention relates to the use of Angiotensin Converting enzyme 2 (ACE2) for the preparation of a medicament for the treatment of severe acute lung injury, especially induced by acid aspiration or sepsis, of lung oedemas and lung injuries and failures connected with infection with severe acute respiratory Syndrome (SARS) Coronavirus.
L'invention concerne l'utilisation de l'enzyme 2 de conversion de l'angiotensine (ACE2) pour préparer un médicament permettant de traiter une lésion pulmonaire grave sévère induite, en particulier, par l'aspiration d'acide ou la sepsis, les oedèmes et les lésions pulmonaires ainsi que les troubles associes à une infection par le coronavirus du syndrome respiratoire aiguë sévère (SARS).
Imai Yumiko
Jiang Chengyu
Kuba Keiji
Penninger Josef
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Imba-Institut Fuer Molekulare Biotechnologie Gmbh
LandOfFree
Use of inhibitors of the renin-angiotensin system for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of inhibitors of the renin-angiotensin system for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of inhibitors of the renin-angiotensin system for the... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1484166